ABSTRACT
INTRODUCTION
When dealing with tissue samples containing small amounts of RNA, such as biopsies, quantitative reverse transcription polymerase chain reaction (RT-PCR) is being increasingly used to quantify mRNA. Whereas generation and use of competitive internal standards that are co-amplified by the same set of primers as the target transcript are frequently discussed, the use of suitable noncompetitive standards is relatively underrepresented in the PCR literature. This may be due to the fact that noncompetitive standards such as the transcripts of the gene for cytoplasmtic β -actin or glyceraldehyde-3-phosphate dehydrogenase ( GAPDH) have long been used as a reference for quantitation in mRNA studies such as Northern blots or RNase protection assays. Whereas the reason for using a noncompetitive standard (i.e., the standardization of the expression of the target transcript to a gene transcript, which is presumed to be subject to only weak transcriptional regulation) is basically the same for all mRNA quantitation methods, some methodological problems are unique to quantitative RT-PCR. One of these is related to the presence of numerous processed pseudogenes or retroposons in the genome of humans and various mammals, which bear high sequence homology [up to 96% in the coding region (5, 9) ] to the mRNAs of β -actin and GAPDH, from which they are probably derived by RT and integration into the genome. Due to the different sizes and migration patterns of genomic DNA and mRNA, this does not constitute a problem in Northern Blots and RNase protection assays. However, when performing RT-PCR, the presence of contaminating genomic DNA in the sample leads to an amplification product, which is identical or close to the size of the amplified reverse-transcribed mRNA and thus not distinguishable from it by conventional electrophoresis on agarose gel. To our knowledge, none of the published primer sequences or commercially available primer pairs for β -actin eliminate this problem (see Figure 1) . One possible solution is the use of RNA free of contaminating genomic DNA. Since this cannot be guaranteed by the preparation method [in our experience, even cesium chloride gradient centrifugation and poly(A) mRNA isolation methods sometimes result in small but still amplifiable DNA contaminations when preparing RNA from tissues], one has to rely on DNase digestion of samples. However, this is time-consuming and leads to a loss of material, which is particularly relevant when dealing with quantitation of mRNA in small samples. We, therefore, have attempted to eliminate the problem by designing new oligonucleotide primers for β -actin from published human (GenBank ® Accession No. D28354; References 7, 8 and 11) and rat (10) sequences, which do not amplify processed pseudogenes. In addition, we have compared the effects of DNA contamination of RNA samples using both primers that do and that do not recognize processed pseudogenes.
MATERIALS AND METHODS

Design of PCR Primers
Due to the high sequence homology between the mRNA of β -actin and the β -actin-related processed pseudogenes, not only in the coding sequence but also in the 5 ′and 3 ′untranslated regions, there is a high likelihood for the co-amplification of genomic DNA when performing RT-PCR. Consequently, there is only a very small number of possible primer pairs, which do not amplify the processed pseudogenes. By detailed sequence analysis, we have identified primer pairs for the human and rat β -actin reverse-transcribed mRNA whose amplification is specific and not hampered by the problem men - Figure 2 shows the alignments of the different primer sequences with the human β -actin mRNA (GenBank Accession No. D28354; Reference 11), the pseudogene sequences (3, 7) used to construct the primers and their relation to the introns of the human β -actin gene (8) .
Extraction of RNA, DNase Digestion and Amplification by RT-PCR
Total RNA was isolated from human hearts by a modification of the singlestep acid guanidium thiocyanate-phenol-chloroform RNA extraction method (1) using TriZOL ™Reagent (Life Technologies, Gaithersburg, MD, USA) according to the manufacturer's protocol. DNase digestion of samples was performed with two different RNasefree DNase I preparations (Boehringer Mannheim, Mannheim, Germany and Ambion, Austin, TX, USA). Briefly, up to 300 µ g of air-dried, ethanol-precipitated RNA were dissolved in the recommended digestion buffers (Boehringer Mannheim: 0.1 M sodium acetate, 5 mM MgSO 4 , pH 5.0; Ambion: 40 mM Tris-HCl, 6 mM MgCl 2 , pH 8.0) and digested with 10 U DNase I for 30 min at room temperature (Boehringer Mannheim) or 5 U DNase I for 15 min at 37°C (Ambion). Afterwards, the RNA was phenol-chloroform-extracted and stored in 100% ethanol at -20°C until used. Following RT (M-MLV Reverse Transcriptase; Life Technologies), the cDNA was amplified using recombinant Taq DNA Polymerase (GoldStar ™ DNA Polymerase; Eurogentec, Seraing, Belgium). The reaction volume was 50 µ L, and 1 µ L of RT product was used as template. The optimal PCR conditions regarding Mg 2+ (2 mM
Comparison of the Effect of Contamination with Genomic DNA Between Different PCR Primers
DNase-digested RNA samples were contaminated with 10 ng of DNA per µ g of total RNA. After RT, a cycle test was performed using commercially available primers (Stratagene) and those designed by us. The amplification conditions were the same as above, except that a 20-µ L oil overlay (light white mineral oil; Sigma Chemical, St. Louis, MO, USA) was used. The ethidium bromide-stained agarose gels were digitized using a video gel documentation system (ImageStore ™5000; UVP, Cambridge, England, UK) and analyzed using the NIH Image computer program (http://rsb.info.nih.gov/nih-image) .
Check of Identity and Specificity of the Amplified Products
Using the above-mentioned conditions for amplification, the PCR products were cloned into a TA cloning vector (The LigATor; R&D Systems, Minneapolis, MN, USA), then cyclesequenced (Thermo Sequenase ™ Kit; Amersham International plc, Little Chalfont, Bucks, England, UK) using 35 S[dATP] according to the manufacturer's protocol and analyzed by migration on a denaturing 6% polyacrylamide gel and subsequent autoradiography.
RESULTSANDDISCUSSION
The use of transcripts of housekeeping genes as controls in RT-PCR serves two main purposes: ( i ) as a positive control, i.e., to ensure that cDNA is present in the reverse-transcribed samples, and ( ii ) as a standard for quantitation, i.e., as a reference to which the expression of the target transcript can be compared. We and others routinely use the transcript of the cytoplasmatic β -actin gene as a positive control because it is ubiquitously expressed and thus can be used to assess the presence of cDNA in the reverse-transcribed sample. However, when using either published (2) or commercially available (Stratagene and CLONTECH) oligonucleotide primers, we could sometimes observe amplification products of the same length in the control samples that are not reverse-transcribed, even when DNA contamination was not apparent on the RNA gel.
When reviewing the literature, we found that based on the methods used, many groups should encounter the same problem. However, it seems to be ignored by most authors (such as in Reference 2) and is expressly stated only rarely; in which case, usually a DNase digestion is performed to circumvent it, such as in Reference 6.
This, however, always leads to a loss of material and is not feasible when dealing with small tissue samples such as human myocardial or renal biopsies. The amount of contaminating genomic DNA also depends strongly on the method used for RNA isolation. In our experience, poly(A) isolation or an additional lithium chloride-precipitation step are the most efficient methods to remove genomic DNA, but even with these methods, complete removal of contaminating DNA, (i.e., failure to amplify processed pseudogenes) cannot be guaranteed. As shown in Figure  1 , primers recognizing processed pseudogenes amplify fragments of contaminating genomic DNA which have the same size as cDNA fragments (RT in lanes A1 and B1 with reverse transcriptase and in lanes A2 and B2 without reverse transcriptase). In contrast, the new primers do not amplify a genomic DNA fragment of the same size as the cDNA fragment (lanes C1 and C2). Both human and rat primers were tested with combinations of different concentrations of primers (0.1-0.4 µ M), MgCl 2 (1.0-3.0 mM) and dNTPs (0.05-0.1 mM each) at different annealing temperatures (52°-63°C). Under conditions of low MgCl 2 (1.0 mM) and high dNTP (0.1 mM each) and primer (0.5 µ M) concentrations, there was only inefficient amplification.
However, under all conditions tested with both human and rat primer sets, we never observed amplification of processed pseudogenes in the control samples that were not reverse-transcribed. After DNase digestion before RT, all primers lead to identical results (lanes A3 and 4, B3 and 4, and C3 and 4); i.e., there is no amplification product observed in the samples that are not reverse-transcribed. The sequence of the cloned and sequenced human and rat fragments amplified with the new oligonucleotide primers were identical to the corresponding parts of the published human (11) and rat (10) pseudogene (v00479, v00481 and m55014) . All alignments shown are for the ± strand, thus the sequences in the figure for the reverse primers are complementary. AA′ : primer pair described in this paper; BB ′: primer pair from Reference 2; CC ′ : primer pair from Stratagene; DD′ : primer pair from CLONTECH.
competitive standard for quantitative RT-PCR, we were interested in the quantitative effect of DNA contamination on the amplification. As a reference for mRNA quantitation, β -actin (as well as other housekeeping genes) has its limitations, and the use of β -actin as a noncompetitive standard is generally not advisable in situations where there is either an acute extensive remodeling of the tissue and/or major morphological changes of the cells. However, the time course and magnitude of the upregulation of its expression in response to cell-specific and nonspecific stimuli are well studied (4) . To assess the quantitative influence of DNA contamination on the PCR results, we contaminated DNase-digested samples with small amounts of genomic DNA before RT (for each µ g of total RNA, we added 10 ng of genomic DNA). We then performed a cycle test; Figure 3 shows the results. DNA contamination only had an effect when using primers that recognize processed pseudogenes. The turning point of the curve was reproducibly shifted between 1 and 2 amplification cycles to the left, suggesting that the presence of genomic DNA may influence the results of quantitative PCR studies. This opinion is apparently shared by others; for example, Haywood and coworkers, who investigated the expression of the inducible nitric oxide synthase in human heart failure, had to exclude samples because of exactly this problem (6) .
CONCLUSION
Primers for transcripts of housekeeping genes that do not recognize processed pseudogenes can be used as reliable positive controls for the presence of cDNA in the sample. They are particularly useful, if the amount of mRNA available is too small to perform a control reaction without RT. Regarding quantitation, the results of our experiments suggest that, depending on whether or not the PCR primers used recognize processed pseudogenes, contamination with genomic DNA in the range of 1% can significantly influence the amount of PCR product when amplifying mRNA of housekeeping genes for which related processed pseudogenes are present in the genome. Since quantitative RT-PCR is particularly useful when dealing with small tissue samples where the amount of RNA available is scarce and the degree of contamination with genomic DNA is likely to be very heterogenous, the use of primers that do not recognize processed pseudogenes such as those presented in this paper for cytoplasmatic β -actin is certainly advantageous.
